Sodium carboxymethyl starch can be used as
pharmaceutical excipients, body immune organ improvement solution, and
thickening agent in food additives.
Facts of Sodium carboxymethyl starch
Sodium
carboxymethyl starch (CMS or SCMS) is a starch ether derivative derived
from starch. It is soluble in water at room temperature and forms a transparent
to light milky and viscous solution. Its synonyms are Carboxymethyl Starch
Sodium Salt, Sodium Starch Glycolate, Carboxymethyl Starch Sodium, CMS-Na,
Na-CMS, Sodium CMS, Modified Starch, Anionic Carboxy Methyl Starch, Anionic
Modified Starch, Starch Gum, CMS, Carboxy Methyl Ethers of Starch. Its CAS
Number is 9063-38-1.
Sodium carboxymethyl starch as
pharmaceutical excipients
Sodium starch glycolate is widely used in
oral pharmaceuticals as a disintegrant in capsule and tablet formulations. It
is recommended to use in tablets prepared by either directcompression or
wet-granulation processes. The dosage is usually 2% to 8% in tablets. Although
2% is sufficient in many cases, the optimal content is 4%. Carboxymethyl sodium
can also be used as a suspending agent.
Sodium carboxymethyl starch solution to
increase body immune organ
Sodium carboxymethyl starch can increase
the body's immune organs (thymus), increase the number of cells; selectively
stimulate T cells, promote T cell maturation and differentiation; promote lymphoblast
transformation, increase the absolute lymphocyte count; increase plasma IgA,
IgG concentrations To improve the body's immunity, reduce the number and
duration of repeated upper respiratory tract infections in children, reduce the
harm to the health and growth of children, and also reduce the content of IgM
in plasma; reduce the content of basophils and reduce basophils The combination
of cell surface receptors and IgE produces an allergic response related to the
onset of asthma, thereby reducing bronchial asthma induced by repeated upper
respiratory infections in children. Therefore, carboxymethyl starch solution is
an immune stimulant, which can stimulate the activity of immune cells, increase
antibody levels, and increase resistance.
Sodium carboxymethyl starch as
thickening agent in food additives
There are about 30 kinds of thickeners in
food additives, they can give foods a thick and suitable mouth feel. The most
common of these thickeners are modified starches and gums, such as sodium
carboxymethyl starch, hydroxypropyl starch, guar gum, xanthan gum, pectin,
gelatin and the like. Thickeners are generally very safe, so there is no limit
to their use in many foods.
Sodium carboxymethyl starch supplier
Shandong Liaocheng Luxi Yaofu Co., Ltd. Is
a factory in China specializing in producing sodium carboxymethyl starch as
pharmaceutical excipients. The results are in compliance. Shandong Liaocheng
Luxi Yaofu Co., Ltd. was established in 2005. The new site is located in the
Houlou Industrial Park in Jiazhai Town, Luanping County, Liaocheng City with
convenient transportation taking up 50 mu of land with total floor area of
148,000 square meters. Business scope: production and management of
pharmaceutical excipients. The company's main products: dextrin,
microcrystalline cellulose, sodium carboxymethyl starch. The product of the
company is tested according to GB 29937-2013 "Food Safety National
Standard Food Additive Carboxymethyl Starch Sodium".
Related news in pharmaceutical industry:
New
lymphoma drug! Roche's first CD79b target ADC drug Polivy qualified as orphan
drug to treat DLB.
The
newly revised Drug Administration Law of China to take effect on December 1,
2019 for better regulation of drug production
2019
China Vitamin C Export, Market Structure and Prospect Introduction
Novartis
announces new strategy to provide innovative medicines to more patients in
sub-Saharan Africa
Health
Highlights: Nov. 18, 2019
£373k awarded to earlier pancreatic
cancer diagnosis research
The newly revised Drug Administration
Law of China to take effect on December 1, 2019 for better regulation of drug
production
Industry of Vitamin A: Supply
Decrease and Market Demand Increase in Short Term
Export of China's nutrition and
health products in the first half of 2019
FDA: Biotin Supplements Could Affect
Results of Medical Tests
CPhI
Annual Report predicts Europe to surpass the USA in biologic manufacturing
capacity by 2023
FDA
approves first therapy to treat patients with rare blood disorder
Protein
could offer therapeutic target for pancreatic cancer